Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease
Open Access
- 2 November 2023
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (1) , 79.e1-79.e10
Abstract
No abstract availableKeywords
Funding Information
- NIH
- University of Massachusetts Amherst
This publication has 42 references indexed in Scilit:
- Human mesenchymal stem cells suppress donor CD4+ T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host diseaseClinical and Experimental Immunology, 2012
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- Bacillus subtilis-Mediated Protection from Citrobacter rodentium-Associated Enteric Disease RequiresespHand Functional FlagellaInfection and Immunity, 2012
- Risk factors for acute GVHD and survival after hematopoietic cell transplantationBlood, 2012
- The EpsE Flagellar Clutch Is Bifunctional and Synergizes with EPS Biosynthesis to Promote Bacillus subtilis Biofilm FormationPLOS Genetics, 2010
- High-dose cyclophosphamide for graft-versus-host disease preventionCurrent Opinion in Hematology, 2010
- Immunoregulatory functions of mTOR inhibitionNature Reviews Immunology, 2009
- Carbohydrate analysis by a phenol–sulfuric acid method in microplate formatAnalytical Biochemistry, 2005
- Acute graft-vs-host diseaseExperimental Hematology, 2001
- Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysisBone Marrow Transplantation, 1998